Jiarui Feng

238 Jiefang Road
Wuhan, 430060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

SHC4 suppresses ferroptosis and promotes sorafenib resistance in hepatocellular carcinoma by disrupting the interaction between NCOA4 and FTH1.

SHC4 suppresses ferroptosis and promotes sorafenib resistance in hepatocellular carcinoma by disrupting the interaction between NCOA4 and FTH1.

Journal: Cellular signalling

Published: February 05, 2026

Association of baseline eosinophil counts with clinical prognosis in cancer patients undergoing immune checkpoint inhibitor therapy.

Association of baseline eosinophil counts with clinical prognosis in cancer patients undergoing immune checkpoint inhibitor therapy.

Journal: iScience

Published: September 19, 2025

RRP9 suppresses hepatocellular carcinoma progression by inhibiting the PI3K/AKT/mTOR pathway.

RRP9 suppresses hepatocellular carcinoma progression by inhibiting the PI3K/AKT/mTOR pathway.

Journal: International journal of oncology

Published: August 27, 2025

Integrative prognostic value of the CALLY index in cancer patients undergoing surgical resection.

Integrative prognostic value of the CALLY index in cancer patients undergoing surgical resection.

Journal: International journal of surgery (London, England)

Published: August 20, 2025

Integrative prognostic value of the CALLY index in cancer patients undergoing surgical resection.

Integrative prognostic value of the CALLY index in cancer patients undergoing surgical resection.

Journal: International journal of surgery (London, England)

Published: August 20, 2025

Prognostic impact of CRAFITY score in hepatocellular carcinoma patients treated with immune checkpoint inhibitors.

Prognostic impact of CRAFITY score in hepatocellular carcinoma patients treated with immune checkpoint inhibitors.

Journal: iScience

Published: July 24, 2025

Clock genes in pancreatic disease progression: from circadian regulation to dysfunction.

Clock genes in pancreatic disease progression: from circadian regulation to dysfunction.

Journal: Annals of medicine

Published: July 13, 2025

Prognostic value of the lactate dehydrogenase to albumin ratio in cancer patients.

Prognostic value of the lactate dehydrogenase to albumin ratio in cancer patients.

Journal: Frontiers in nutrition

Published: April 15, 2025

Downregulation of Bmal1 Expression in Celiac Ganglia Protects against Hepatic Ischemia-Reperfusion Injury.

Downregulation of Bmal1 Expression in Celiac Ganglia Protects against Hepatic Ischemia-Reperfusion Injury.

Journal: Biomolecules

Published: March 03, 2023

Blood biomarkers predict outcomes in patients with hepatocellular carcinoma treated with immune checkpoint Inhibitors: A pooled analysis of 44 retrospective sudies.

Blood biomarkers predict outcomes in patients with hepatocellular carcinoma treated with immune checkpoint Inhibitors: A pooled analysis of 44 retrospective sudies.

Journal: International immunopharmacology

Published: December 02, 2022

Inhibition of Notch activity promotes pancreatic cytokeratin 5-positive cell differentiation to beta cells and improves glucose homeostasis following acute pancreatitis.

Inhibition of Notch activity promotes pancreatic cytokeratin 5-positive cell differentiation to beta cells and improves glucose homeostasis following acute pancreatitis.

Journal: Cell death & disease

Published: June 05, 2021

Circular RNA CDR1as promotes tumor progression by regulating miR-432-5p/E2F3 axis in pancreatic cancer.

Circular RNA CDR1as promotes tumor progression by regulating miR-432-5p/E2F3 axis in pancreatic cancer.

Journal: Cancer cell international

Published: November 17, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026